Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07766642

A Clinical Trial to Evaluate the Effects of a Supplement on Children's Focus and Energy

This study will evaluate the effects of the Auri Super Mushroom Daily Gummies For Kids on focus and energy in children aged 4-12. The study is a single-arm, unblinded, virtual trial conducted over 8 weeks, in which all 35 enrolled participants will use the test product daily.

Parents of the participants will complete questionnaires at Baseline, Week 2, Week 4, Week 6, and Week 8 to assess perceived changes in their child's focus, attention, sleep quality, gut health, natural energy, and overall well-being. Participants will also undergo cognitive battery testing at Baseline, Week 4, and Week 8 to provide objective measurements of focus and cognitive performance.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

4 year–12 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Citruslabs

Las Vegas, Nevada, 89101, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Be male or female.
  • Be aged 4-12.
  • Parent(s) reporting that their child has been experiencing issues regarding any of the following for the past four weeks: Difficulty focusing, Poor concentration, or Poor memory.
  • Parent(s) who report that their child will be willing to complete cognitive assessments at regular intervals during the study.
  • Any child who is generally healthy - does not live with any uncontrolled chronic disease.
  • Parent(s) who are willing to follow the study protocol and support their child to complete all study actions.
  • Any child who has no planned changes to school schedule, sleep routines, or behavioral therapies during the study duration.
  • Anyone willing to refrain from introducing any new prescription medications, wellness products, supplements, or herbal remedies into their child's routine during the test period.
  • If the child has been taking any other products, supplements, or herbal remedies, they have been taking these consistently for at least three months.
  • Has had a stable diet and sleep schedule for at least four weeks prior to the study.
  • Enrolled in and currently attending school at baseline and for the duration of the study period.
  • Resides in the United States.

Exclusion criteria

  • Any child with a neurodevelopmental condition or developmental delay, including autism spectrum disorder, intellectual disability, language disorder, uncontrolled anxiety or mood disorder, or dyslexia.
  • Previous diagnosis of Attention-deficit hyperactivity disorder (ADHD).
  • Any child currently undergoing any assessments for suspected neurodevelopmental conditions or developmental delay.
  • Any child diagnosed with epilepsy or a seizure disorder.
  • Any child diagnosed with a bleeding disorder.
  • Any child with any known allergies or hypersensitivities to any supplement product ingredients.
  • Any child with any chronic health conditions that could impact their participation in this study, such as cancer, mental health disorders, a history of serious illness in the last three months, or planned surgery during the study period.
  • Any parent or child currently testing, or planning on starting in the next eight weeks, a product for another research study.

Treatment and study plan

Auri Super Mushroom Daily Gummies For Kids

Dietary Supplement

All participants receive two Auri Super Mushroom Daily Gummies once daily in the morning with their first meal of the day for 8 weeks.

Primary outcomes

  1. Change in Focus

    Time frame: Baseline, Week 4, and Week 8

    Assessed via cognitive battery testing (Polygons, Double Trouble, Feature Match, Paired Associates, Digit Span, Spatial Planning) and self-reported questionnaire

  2. Change in Cognitive Performance

    Time frame: Baseline, Week 4, and Week 8

    Assessed via cognitive battery testing (Polygons, Double Trouble, Feature Match, Paired Associates, Digit Span, Spatial Planning) and self-reported questionnaire

Secondary outcomes

  1. Change in Parent-Reported Focus

    Time frame: Baseline, Week 2, Week 4, Week 6, and Week 8

    Assessed via parent-completed self-reported questionnaire

  2. Change in Parent-Reported Attention

    Time frame: Baseline, Week 2, Week 4, Week 6, and Week 8

    Assessed via parent-completed self-reported questionnaire

  3. Change in Parent-Reported Sleep Quality

    Time frame: Baseline, Week 2, Week 4, Week 6, and Week 8

    Assessed via parent-completed self-reported questionnaire

  4. Change in Parent-Reported Gut Health

    Time frame: Baseline, Week 2, Week 4, Week 6, and Week 8

    Assessed via parent-completed self-reported questionnaire

  5. Change in Parent-Reported Natural Energy

    Time frame: Baseline, Week 2, Week 4, Week 6, and Week 8

    Assessed via parent-completed self-reported questionnaire

  6. Change in Parent-Reported Overall Well-Being

    Time frame: Baseline, Week 2, Week 4, Week 6, and Week 8

    Assessed via parent-completed self-reported questionnaire

Sponsors and collaborators

Lead sponsor

Auri Nutrition

Industry

Collaborators

  • Citruslabs

Registry information

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Aug 14, 2026
Registry last updated
Aug 14, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.